| 摘要 |
The invention is concerned with novel carbocyclyl fused cyclic amines of formula (I) wherein A, X<SUP>1</SUP> to X<SUP>3</SUP>, Y<SUP>1</SUP> to Y<SUP>3</SUP>, Z, R<SUP>1</SUP>, R<SUP>2</SUP>, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments. |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;BOEHRINGER, MARKUS;GROEBKE ZBINDEN, KATRIN;HAAP, WOLFGANG;PANDAY, NARENDRA;RICKLIN, FABIENNE;STAHL, MARTIN;SCHMITZ, PETRA |
发明人 |
BOEHRINGER, MARKUS;GROEBKE ZBINDEN, KATRIN;HAAP, WOLFGANG;PANDAY, NARENDRA;RICKLIN, FABIENNE;STAHL, MARTIN;SCHMITZ, PETRA |
